Clinical trial
Evaluation of the Efficacy of Autologous Bone Marrow-Derived Mononuclear Cell Transplantation in the Treatment of Cerebral Palsy Due to Brain Hypoxia: A Phase II Randomized Clinical Trial
NCT06629324 is registered in ClinicalTrials.gov with Vinmec Research Institute of Stem Cell and Gene Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy of Autologous Bone Marrow-Derived Mononuclear Cell Transplantation in the Treatment of Cerebral Palsy Due to Brain Hypoxia: A Phase II Randomized Clinical Trial
- Lead sponsor
- Vinmec Research Institute of Stem Cell and Gene Technology
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- October 15, 2024
- Completion date
- January 31, 2027
- Enrollment
- 58 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.